See more : Softline AG (SFD1.DE) Income Statement Analysis – Financial Results
Complete financial analysis of MedMen Enterprises Inc. (MMNFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MedMen Enterprises Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Hakuto Co., Ltd. (7433.T) Income Statement Analysis – Financial Results
- Fab-Form Industries Ltd. (FBF.V) Income Statement Analysis – Financial Results
- Foxtons Group plc (FXTGY) Income Statement Analysis – Financial Results
- CAE Inc. (CAE) Income Statement Analysis – Financial Results
- Rastar Environmental Protection Materials Co.,Ltd. (300834.SZ) Income Statement Analysis – Financial Results
MedMen Enterprises Inc. (MMNFF)
About MedMen Enterprises Inc.
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the MedMen Red and LuxLyte brand names. As of December 25, 2021, it operated 29 stores in California, Florida, Nevada, Illinois, Arizona, Massachusetts, and New York. MedMen Enterprises Inc. is headquartered in Culver City, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 140.81M | 145.07M | 157.11M | 129.96M | 39.78M | 2.67M | 20.07K | 26.65K | 20.64K | 24.92K | 19.66K | 27.66K | 18.14K | 33.60K | 36.42K | 22.18K | 20.28K | 19.34K | 30.11K | 0.00 | 305.46K |
| Cost of Revenue | 71.08M | 77.78M | 98.99M | 69.09M | 25.93M | 1.80M | 7.89K | 7.66K | 7.96K | 7.78K | 9.02K | 10.70K | 9.33K | 10.32K | 9.36K | 10.82K | 8.19K | 7.78K | 19.30K | 0.00 | 395.02K |
| Gross Profit | 69.73M | 67.29M | 58.12M | 60.88M | 13.85M | 868.14K | 12.18K | 19.00K | 12.69K | 17.14K | 10.63K | 16.96K | 8.81K | 23.28K | 27.06K | 11.36K | 12.08K | 11.56K | 10.81K | 0.00 | -89.56K |
| Gross Profit Ratio | 49.52% | 46.39% | 36.99% | 46.84% | 34.81% | 32.49% | 60.69% | 71.27% | 61.46% | 68.78% | 54.09% | 61.32% | 48.56% | 69.30% | 74.31% | 51.23% | 59.59% | 59.76% | 35.90% | 0.00% | -29.32% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 108.72M | 124.59M | 200.27M | 234.65M | 98.18M | 14.14M | 136.18K | 240.61K | 133.04K | 236.99K | 53.70K | 28.22K | 41.69K | 41.73K | 11.11K | 8.91K | 9.37K | 19.11K | 45.59K | 0.00 | 0.00 |
| Selling & Marketing | 3.21M | 1.11M | 10.64M | 27.55M | 7.01M | 323.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 111.93M | 125.70M | 210.92M | 262.20M | 105.20M | 14.46M | 136.18K | 240.61K | 133.04K | 236.99K | 53.70K | 28.22K | 41.69K | 41.73K | 11.11K | 8.91K | 9.37K | 19.11K | 45.59K | 74.82K | 171.76K |
| Other Expenses | 19.10M | 30.89M | 39.95M | 20.98M | 5.26M | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 216.33K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 131.03M | 156.59M | 250.87M | 283.17M | 110.45M | 15.66M | 136.18K | 240.61K | 133.04K | 236.99K | 53.70K | 28.22K | 41.69K | 41.73K | 11.11K | 8.91K | 9.37K | 19.11K | 45.59K | 74.82K | 179.99K |
| Cost & Expenses | 202.11M | 234.37M | 349.86M | 352.26M | 136.39M | 17.46M | 144.07K | 248.26K | 140.99K | 244.77K | 62.73K | 38.92K | 51.02K | 52.05K | 20.47K | 19.73K | 17.56K | 26.90K | 64.89K | 74.82K | 575.01K |
| Interest Income | 91.59K | 649.23K | 766.04K | 701.79K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 43.07M | 61.37M | 49.49M | 22.82M | 16.11M | 512.44K | 135.37 | 6.53K | 2.46K | 30.07K | 35.41K | 34.97K | 35.93K | 30.44K | 37.00K | 31.38K | 29.77K | 17.16K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 25.74M | 34.46M | 43.71M | 23.54M | 5.15M | 1.57M | 22.82K | 6.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 216.33K | 0.00 | 10.08K | 0.00 | 0.00 |
| EBITDA | -35.56M | -54.84M | -149.04M | -198.75M | -91.45M | -13.22M | -124.01K | -221.61K | -120.35K | -219.85K | -43.07K | -11.26K | -32.88K | -18.45K | 15.95K | 2.45K | 219.04K | -7.55K | -24.71K | -74.82K | -269.55K |
| EBITDA Ratio | -25.26% | -37.81% | -94.86% | -152.93% | -229.87% | -494.85% | -618.00% | -831.49% | -582.98% | -882.08% | -219.12% | -40.73% | -181.26% | -54.90% | 43.80% | 11.04% | 1,080.18% | -39.05% | -82.07% | 0.00% | -88.24% |
| Operating Income | -61.30M | -89.30M | -192.75M | -222.30M | -96.60M | -14.79M | -124.01K | -228.14K | -120.35K | -219.85K | -43.07K | -11.26K | -32.88K | -18.45K | 15.95K | 2.45K | 2.72K | -7.55K | -34.79K | -74.82K | -269.55K |
| Operating Income Ratio | -43.53% | -61.56% | -122.68% | -171.05% | -242.83% | -553.54% | -618.00% | -855.98% | -582.98% | -882.08% | -219.12% | -40.73% | -181.26% | -54.90% | 43.80% | 11.04% | 13.40% | -39.05% | -115.55% | 0.00% | -88.24% |
| Total Other Income/Expenses | -114.15M | -67.40M | -328.92M | -22.30M | -11.01M | -2.91M | -18.81 | 0.00 | -2.46K | -30.07K | -35.41K | -34.97K | -35.93K | -30.44K | -37.00K | -31.38K | 186.55K | -17.16K | 360.22K | 0.00 | -1.00M |
| Income Before Tax | -175.45M | -143.61M | -515.35M | -263.23M | -110.73M | -15.38M | -124.14K | -228.14K | -122.80K | -249.92K | -78.48K | -46.23K | -68.81K | -48.88K | -21.05K | -28.93K | 189.27K | -24.72K | 325.43K | 0.00 | -1.27M |
| Income Before Tax Ratio | -124.60% | -99.00% | -328.01% | -202.54% | -278.32% | -575.46% | -618.67% | -855.98% | -594.87% | -1,002.74% | -399.26% | -167.16% | -379.31% | -145.49% | -57.81% | -130.46% | 933.37% | -127.80% | 1,080.98% | 0.00% | -416.30% |
| Income Tax Expense | -9.90M | 1.83M | -39.60M | 13.81M | 1.54M | 43.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.77K | 0.00 | 0.00 | 75.18K | 0.00 |
| Net Income | -165.55M | -145.45M | -475.75M | -277.05M | -112.26M | -15.42M | -124.14K | -228.14K | -122.80K | -249.92K | -78.48K | -46.23K | -68.81K | -48.88K | -21.05K | -28.93K | 189.27K | -24.72K | 325.43K | -75.18K | -1.27M |
| Net Income Ratio | -117.57% | -100.26% | -302.81% | -213.17% | -282.19% | -577.07% | -618.67% | -855.98% | -594.87% | -1,002.74% | -399.26% | -167.16% | -379.31% | -145.49% | -57.81% | -130.46% | 933.37% | -127.80% | 1,080.98% | 0.00% | -416.30% |
| EPS | -0.14 | -0.27 | -1.76 | -2.62 | -2.77 | -26.33 | -0.21 | -0.56 | -0.50 | -0.93 | -1.76 | -1.03 | -1.54 | -1.09 | -0.47 | -0.65 | 4.24 | -0.55 | 7.28 | -1.68 | -28.73 |
| EPS Diluted | -0.14 | -0.27 | -1.76 | -2.62 | -2.77 | -26.33 | -0.21 | -0.56 | -0.50 | -0.93 | -1.76 | -1.03 | -1.54 | -1.09 | -0.47 | -0.65 | 4.24 | -0.55 | 7.28 | -1.68 | -28.73 |
| Weighted Avg Shares Out | 1.15B | 530.98M | 270.42M | 105.92M | 40.48M | 585.58K | 585.58K | 410.57K | 245.24K | 268.30K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.26K |
| Weighted Avg Shares Out (Dil) | 1.15B | 530.98M | 270.42M | 105.92M | 40.48M | 585.58K | 585.58K | 410.57K | 245.24K | 268.30K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.67K | 44.26K |
Top Marijuana Penny Stocks To Watch Next Week? 2 For Your List In November
Top Marijuana Penny Stocks Under $1 In November The post Top Marijuana Penny Stocks To Watch Next Week? 2 For Your List In November appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
MedMen To Announce First Quarter Fiscal 2022 Financial Results on November 9, 2021
LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, confirmed that it will release its financial results for the first quarter fiscal 2022 ended September 25,...
MedMen To Announce First Quarter Fiscal 2022 Financial Results on November 9, 2021
LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, confirmed that it will release its financial results for the first quarter fiscal 2022 ended September 25,...
MedMen Appoints New COO: Roz Lipsey Takes The Reins
Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) announced Monday it has promoted Roz Lipsey to a chief operating officer, succeeding Tim Bossidy, who has served as an interim COO since 2020. Lipsey has been part of the company's executive management team...
MedMen Announces Re-Opening of Tallahassee, Florida Location
LOS ANGELES--(BUSINESS WIRE)--MedMen announces Tallahassee store re-opening.
2 Hot Marijuana Stocks To Watch This Week
These Marijuana Stocks Gaining More Attention In 2021 The post 2 Hot Marijuana Stocks To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Top Marijuana Penny Stocks To Watch Mid October
Are Top Cannabis Penny Stocks A Buy In October? The post Top Marijuana Penny Stocks To Watch Mid October appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Tilray's DCF: Aphria, MedMen, And More Innovation Mean Upside Potential
Tilray's DCF: Aphria, MedMen, And More Innovation Mean Upside Potential
Ousted MedMen Executives File Suit Against Their Own Company
A company run by the ousted co-founders of cannabis giant MedMen, Adam Bierman and Andrew Modlin, are suing Coastal Holding Co., a company that holds several cannabis licenses in multiple California cities, over planning to sell the company for $56.2 million,...
LitHouse Farms to Manage MedMen's California And Nevada-Based Cultivation Facilities
Cannabis retailer MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) disclosed Friday that LitHouse Farms will oversee operations at the two facilities it leases in Desert Hot Springs, California and Sparks, Nevada. The Califonia cultivator agreed to manage growing and manufacturing at each...
Source: https://incomestatements.info
Category: Stock Reports